Paper31972425
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P and 8 others. Int Immunopharmacol, 2020. Cited by 817 papers, by iCite.
Cite this record
ConductScience Library. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Papers, record 31972425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31972425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immune System Diseases | Major topic |
| Inflammation | Major topic |
| Janus Kinases | Major topic |
| Protein Kinase Inhibitors | Major topic |
| STAT Transcription Factors | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Cytokines | |
| Disease Models, Animal | |
| Humans |
Source PubMed
Cited by553
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 817 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42980878 | Integrative molecular profiling of TAM receptors and STAT-SOCS signaling in thymic epithelial tumors. | Med Oncol | 2026 | https://conductscience.org/library/papers/42980878 | PubMed |
| 42979449 | Irisin Protects Against Seawater Aspiration-Induced Acute Lung Injury via Inhibiting JAK2/STAT1 Signal Pathway. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42979449 | PubMed |
| 42979230 | JAK-STAT signaling: a key mechanism of immune microenvironment remodeling in breast cancer and novel strategies for targeted therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42979230 | PubMed |
| 42979192 | Research advances in Janus kinase inhibitors for immune checkpoint inhibitors-related myocarditis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979192 | PubMed |
| 42968959 | Mechanism Analysis of Chronic Inflammation in Polycystic Ovary Syndrome and Targeted Therapeutic Strategies Based on Bioactive Constituents of Traditional Chinese Medicine. | Int J Womens Health | 2026 | https://conductscience.org/library/papers/42968959 | PubMed |
| 42967202 | Enhancing Immune Tolerance and Insulin Secretion of Mesenchymal Stem Cell-Derived Insulin-Producing cells via Interferon-γ and Tumor Necrosis Factor-α Priming. | Rep Biochem Mol Biol | 2025 | https://conductscience.org/library/papers/42967202 | PubMed |
| 42942521 | Expression of STAT3 and STAT6 in Men with Large Versus Small Prostates Undergoing Transurethral Resection of the Prostate. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942521 | PubMed |
| 42924606 | Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42924606 | PubMed |
| 42923801 | Chinese expert consensus on the treatment of immune‑mediated inflammatory diseases with Janus kinase inhibitors. | Rheumatol Immunol Res | 2026 | https://conductscience.org/library/papers/42923801 | PubMed |
| 42918627 | Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians. | J Crohns Colitis | 2026 | https://conductscience.org/library/papers/42918627 | PubMed |
| 42908038 | Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort. | BMC Pharmacol Toxicol | 2026 | https://conductscience.org/library/papers/42908038 | PubMed |
| 42835412 | Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42835412 | PubMed |
| 42819305 | Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42819305 | PubMed |
| 42807881 | Inter-organ crosstalk in systemic inflammation: a narrative review of molecular mechanisms and pharmacological modulation in the muscle-adipose-liver axis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42807881 | PubMed |
| 42794640 | Bicyclol: A Useful Agent for Silicosis? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794640 | PubMed |
| 42773186 | Advances in the role of astrocytes in glioma progression and therapy. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42773186 | PubMed |
| 42763828 | Upstream regulatory mechanisms and clinical significance of IQGAP2 deficiency in affecting PI3K activity to drive cell proliferation. | Hum Cell | 2026 | https://conductscience.org/library/papers/42763828 | PubMed |
| 42747144 | Population-Level Burden of Dermatitis and the Effects of Moxibustion and Capsaicin on Pruritus and JAK/STAT Signaling in Atopic Dermatitis: A Multilevel Study. | Mediators Inflamm | 2026 | https://conductscience.org/library/papers/42747144 | PubMed |
| 42736381 | Montelukast attenuates intestinal mucositis induced by 5-fluorouracil via upregulation of HO-1 and PPAR-γ and suppression of TLR4/NF-κB/HMGB1 and caspase-3 pathways. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42736381 | PubMed |
| 42718661 | Impact of acute stress on gastric interstitial cells of Cajal disorder. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42718661 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31972425
GET https://conductscience.org/api/papers/v1/31972425/cited_by?page=2